RPG Life Sciences Limited
RPG LIFE SCIENCES recommended a final dividend of Rs.300 per equity share at its board meeting held on April 29, 2026. The record date for the dividend and the date for the Annual General Meeting (AGM) are yet to be fixed by the company.
Apr 29 2026 21:04:00
RPG Life Sciences Ltd - 532983 - Amendment To The Code
RPG Life Sciences Board approved Q4 & FY26 audited financial results and recommended a final dividend of Rs.24 per share for FY26, subject to shareholder approval. The board also appointed Dr. Pratit Samdani as an Additional Non-Executive Independent Director for five years.
Apr 29 2026 21:04:00
RPG Life Sciences Ltd - 532983 - Corporate Action-Board to consider Dividend
RPG Life Sciences' Board recommended a final dividend of ₹24 per equity share for FY26. This payout, 300% of face value, is subject to shareholder approval and will be dispatched within 30 days.
Apr 29 2026 20:04:00
RPG Life Sciences Ltd - 532983 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
RPG Life Sciences announced strong FY26 results with revenue growing 8.3% YoY to Rs. 707.5 cr and Q4 revenue up 23.6% to Rs. 176.9 cr. The board also recommended a Rs. 24 per share final dividend, reflecting healthy profitability and operational momentum.
Apr 29 2026 20:04:00
RPG Life Sciences Ltd - 532983 - Board Meeting Outcome for Outcome Of Board Meeting
RPG Life Sciences announced Q4 FY26 cons. revenue of ₹176.89 cr (up 23.62% YoY) and net profit of ₹29.90 cr (down 74.53% YoY). Full-year FY26 cons. revenue stood at ₹707.52 cr (up 8.28%) and net profit at ₹115.17 cr (down 37.15%). Additionally, the board recommended a final dividend of ₹24 per share for FY26.
Apr 29 2026 20:04:00
RPG Life Sciences Limited
RPG Life Sciences is holding an earnings call on April 30, 2026, at 3:30 PM IST. The call will cover the company's audited financial results for Q4 FY26 and the period ended March 31, 2026, with an investor presentation to follow.
Apr 23 2026 21:04:00
RPG Life Sciences Limited
RPG Life Sciences is holding an earnings call on April 30, 2026, at 3:30 PM IST. The call will cover the company's audited financial results for Q4 FY26 and the period ended March 31, 2026, with an investor presentation to follow.
Apr 23 2026 21:04:00
RPG Life Sciences Limited
RPG Life Sciences board will convene on April 29, 2026, to review and approve its audited standalone and consolidated financial results for the year ended March 2026. The meeting will also include consideration for recommending a final dividend.
Apr 22 2026 19:04:00
RPG Life Sciences Ltd - 532983 - Board Meeting Intimation for The Company Has Informed BSE That The Meeting Of The Board Of Directors Of The Company Is Scheduled On 29Th April, 2026
RPG Life Sciences' Board will meet on April 29, 2026, to approve audited financial results for Q4 FY26 and the full FY26. The meeting will also consider recommending a dividend for the financial year ended March 31, 2026.
Apr 22 2026 19:04:00
RPG Life Sciences Ltd - 532983 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
Clarus Capital I, a scheme of Clarus Trust, and PAC ClearEdge LLC acquired 0.88% equity in RPG Life Sciences Limited via open market. This increased their aggregate shareholding to 5.41%, crossing the disclosure threshold.
Apr 20 2026 13:04:00
Read More